Navigation Links
John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
Date:6/4/2010

ated to cutaneous T-cell lymphoma when other treatments have not been effective. It is a histone deacetylase (HDAC) inhibitor, the first in a class of drugs that regulate enzymes involved in cell signaling. Vorinostat is also being investigated as a treatment option for a range of other solid and hematologic malignancies.

The researchers looked at safety and tolerability data from patients in phase I and II Merck-sponsored clinical trials who received vorinostat as a single (monotherapy) or combination therapy for a variety of cancers. Data from these unblinded trials showed that vorinostat has an acceptable safety and tolerability profile when given as monotherapy, or more commonly in a combination regimen, for patients with refractory metastatic cancer.

Denileukin diftitox shows promise for newly diagnosed T-cell lymphoma patients (the CONCEPT trial). (Abstract number 8045; poster session, June 4, 5:00 6:00 p.m.)

As part of the multicenter CONCEPT trial, Dr. Goy tested the efficacy and safety of denileukin diftitox, a genetically engineered fusion protein that targets cancers that express the interleukin-2 receptor. The drug was tested head-to-head against the standard "CHOP" (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy regimen in a Phase II study in which the patients receiving the new drug were also treated with CHOP. The study group consisted of patients newly diagnosed with aggressive T-cell lymphomas. Researchers found the combination therapy effective, with a 68% overall response rate and 57% complete response rate. As a result, they are starting a multicenter comparison study.


'/>"/>

Contact: Amy Leahing
amy.leahing@widmeyer.com
646-213-7245
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
2. John Theurer Cancer Center offers breakthrough radiation measurement technology
3. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
4. Researchers at the John Theurer Cancer Center Present Cutting-Edge Research Results at this Years American Society of Hematology Annual Meeting
5. AACR Adds to Growing STAR P-2 trial; Publishes Update and Perspectives in Cancer Prevention Research
6. Stage II and stage III colon cancer patients treated after 1995 have improved overall survival
7. Cysts hold clues to pancreatic cancer
8. Interruption of Menstrual Cycle by Chemotherapy Associated with Improved Survival in Early Breast Cancer
9. Olive-oil enriched diet helps breast cancer survivors lose more weight
10. Longer Drug Regimen Still Best Against Breast Cancer
11. Sun-induced skin cancer: new discovery permits doctors to assess genetic risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Branchburg, NJ (PRWEB) June 02, 2015 ... independent verification for non-GMO products made according to ... avoidance. Verified products are produced in compliance with ... testing of all GMO risk ingredients, facility inspections ... possible standards for GMO avoidance. , “Savoury Systems ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Consumer ... consumer organization, today announced its commitment to help ... to the use of antibiotics sicken about 2.25 ... to the Centers for Disease Control and Prevention. ... President and CEO Marta Tellado participating in the ...
(Date:6/2/2015)... June 02, 2015 Robert LaPrade, ... Officer at the Steadman Philippon Research Institute, participated in ... for Single Sport Specialization? ” This was a collaborative ... (AOSSM) Research Committee that was recently published in the ... this project was limited, there is evidence that early ...
(Date:6/2/2015)... While the movie box office may be ... books themselves are stepping into a new role: that ... produce educational comics in multiple languages that will explain ... - an international effort to address humanity’s most pressing ... energy, inequality, climate change and more. , “The United ...
(Date:6/2/2015)... North Vancouver, B.C., Canada (PRWEB) June 02, 2015 ... American publisher of audit, compliance and risk ... of a new online risk management effectiveness gap-improvement ... reduce the effect of uncertainty on objectives. Organizations ... but they improve their capabilities to do this ...
Breaking Medicine News(10 mins):Health News:Savoury Systems International Receives Non-GMO Project Verification Continuing its Commitment to Provide Customers with Clean Label Ingredients 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 2Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 3Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4
... Quarter Revenue of $74.6 Million - , ... Guidance -Fourth Quarter and Full Year 2008 Highlights:- Fourth quarter ... quarter 2007- Full year 2008 total revenue of $250.1 million; ... the second half 2008 of $10 million; exceeds prior guidance ...
... All, Will Solve Crisis and Cut Costs OAKLAND, Calif., ... nurses today praised President Obama,s call for "comprehensive" healthcare ... emphasized that only genuine reform, as in expanding Medicare ... and rein in the skyrocketing costs that the president ...
... Feb. 25 Medarex, Inc. (Nasdaq: MEDX ) ... ended December 31, 2008. Medarex,s net loss for the year ... share, as compared to a net loss of $27.1 million, ... 2008 includes a gain of $151.8 million, or $1.18 per ...
... , , WEDNESDAY, Feb. 25 (HealthDay News) -- U.S. ... drug applications from a Ranbaxy Laboratories plant in India ... Ranbaxy, based in India, is one of the largest ... , "We took this action after it became apparent ...
... of Craneware,s 10th Anniversary YearATLANTA, Feb. 25 Craneware (AIM: CRW.L), ... health systems, is pleased to announce its interim results for the ... , Total of $21.8m ... 28% ...
... Ranbaxy has just received a letter and information ... Paonta Sahib facility have been added to a list ... "AIP". Ranbaxy will analyze the letter and other ... FDA has said it has no evidence the drugs ...
Cached Medicine News:Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 2Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 3Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 4Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 5Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 6Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 7Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 8Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 9Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 10Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 11Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 12Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 13Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 14Health News:NuVasive Reports Fourth Quarter and Full Year 2008 Financial Results 15Health News:Nurses Welcome President's Call for Comprehensive Health Reform 2Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 2Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 3Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 4Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 5Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 6Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 7Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 8Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 9Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 10Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 11Health News:Medarex Announces 2008 Fourth Quarter and Year End Financial Results 12Health News:FDA Halts New Applications From Indian Drug Maker's Plant 2Health News:Craneware Announces Half-Year Results 2Health News:Press Statement Issued by Ranbaxy Laboratories Limited 2
(Date:6/2/2015)... today they are expanding their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 ...
(Date:6/2/2015)... 2015  CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached an agreement to settle ... Delaware Court of Chancery, which names as ... directors and officers, and names the Company as a ... re CytRx Corp. Stockholder Derivative Litigation , C.A. No. ...
(Date:6/2/2015)... ACTON, Mass. , June 2, 2015  Psychemedics ... global leader for over twenty-five years, announced the addition ... panels. In response to growing abuse concerns, the addition ... panel and D-Amphetamine/Adderall® was added as an option to ... , Chairman and CEO stated:  "Sadly, more and more ...
Breaking Medicine Technology:Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Psychemedics Announces Addition Of FDA Cleared Drugs 2Psychemedics Announces Addition Of FDA Cleared Drugs 3
... Inc. (Nasdaq: BNVI ) announced today that it ... year 2010 ended September 30, 2010 on Thursday, November 11, ... to review the financial results on Thursday, November 11, 2010 ... the call by dialing (877) 317-6789 or (412) 317-6789, or ...
... 4, 2010 ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ... Brian M. Culley, will present at the Wall Street Analyst ... 2010 at 12:50 p.m. Eastern time, at The University Club ... a live audio webcast and slide presentation on the Company,s ...
Cached Medicine Technology:
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... tubes contain a buffered sodium ... with a citrate concentration of ... mol/l (3.8%). The mixing ratio ... to 9 parts blood. In ...
... Cross-match tubes are available ... serum tube contains a clotting ... cross-match tests where serum is ... EDTA cross-match tube is suitable ...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: